NCT07301138 BEBT-908 Plus Chemotherapy Treatment for CR MRD-Positive MEF2D-Rearranged and Pre-B Acute Lymphoblastic Leukemia Patients Status NOT_YET_RECRUITING Phase PHASE2
NCT07295951 A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia Status RECRUITING Phase PHASE1
NCT07284927 Clinical Study of LV009 Injection for the Treatment of Hematologic and Lymphoid Malignancies Status RECRUITING Phase PHASE1
NCT07228741 Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity Status RECRUITING Phase PHASE2
NCT07203742 The Effect of Mandala on Anxiety and Fear Levels in Children With Leukemia Before Intrathecal Chemotherapy Treatment Status RECRUITING Phase NA
NCT07203352 Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALL Status RECRUITING Phase PHASE3
NCT07192237 Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic Leukemia Status NOT_YET_RECRUITING Phase PHASE2
NCT07175415 HEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological Malignancies Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07072494 CD19 CAR-T Cell Infusion as Consolidation Therapy in Adolescent and Adult Patients With Acute B-ALL Ineligible for Allogeneic HSCT: A Clinical Study Status RECRUITING Phase PHASE1/PHASE2
NCT07039383 A Real-world Study of the Effectiveness of Tisagenlecleucel in Acute Lymphoblastic Leukemia Patients Status COMPLETED Phase N/A
NCT07020533 A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant Status RECRUITING Phase PHASE1
NCT07016165 Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies Status RECRUITING Phase PHASE4
NCT06985485 Full-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline Chemotherapy Status RECRUITING Phase PHASE2
NCT06918080 Hepatoprotective Measures for Children at High Risk of NAFLD Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT06918054 Hepatoprotective for Children and Adolescent With Acute Lymphoblastic Leukemia Status RECRUITING Phase PHASE4
NCT06894693 A Phase I Clinical Trial of RS001 in Patients with Relapsed/Refractory B-Cell Malignancies Status NOT_YET_RECRUITING Phase PHASE1
NCT06886074 Efficacy of Short-course Blinatumomab for MRD Erradication in B-ALL Status RECRUITING Phase PHASE2